Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Piotrkow Trybunalski – page 2

44 clinical trials in Piotrkow Trybunalski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Piotrkow Trybunalski at a glance
44
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

44 trials in Piotrkow Trybunalski

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Dermatitis atopic

Not yet recruiting

A Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Prostate cancer

Not yet recruiting

Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Jiangsu Hengrui Pharmaceuticals Co. Ltd.

Angina pectoris

Not yet recruiting

Study on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
  • Sponsor:Tasly Pharmaceuticals Inc.

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus+2

Not recruiting

A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Cardiac failure

Not recruiting

Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Piotrkow Trybunalski

What the registry says about research in the country

01 Oncology Research

Studies focusing on innovative treatments for bladder cancer, including combinations with immunotherapy agents and novel therapeutic approaches for head and neck cancer. Multiple trials are evaluating new combination therapies for prostate cancer.

  • Non-muscle invasive bladder cancer treatments
  • Head and neck squamous cell carcinoma therapies
  • Metastatic prostate cancer interventions

Research emphasizes improving survival rates and treatment outcomes through targeted therapies.

02 Cardiovascular Studies

Comprehensive research into heart failure treatments, particularly focusing on reduced ejection fraction conditions. Studies evaluate new medications for stroke prevention in patients with atrial fibrillation.

  • Heart failure management strategies
  • Stroke prevention therapies
  • Cardiovascular disease prevention

Trials aim to improve patient outcomes and develop more effective treatment options.

03 Autoimmune Conditions

Innovative research targeting multiple sclerosis, rheumatoid arthritis, and Sjögren's syndrome. Studies evaluate novel therapeutic approaches and biosimilar medications.

  • Multiple sclerosis treatments
  • Rheumatoid arthritis therapies
  • Inflammatory bowel disease interventions

Focus on developing targeted treatments to improve disease management and patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.